BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 22950660)

  • 1. Effect of luteal-phase support on endometrial microRNA expression following controlled ovarian stimulation.
    Zhao Y; Zacur H; Cheadle C; Ning N; Fan J; Vlahos NF
    Reprod Biol Endocrinol; 2012 Sep; 10():72. PubMed ID: 22950660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endometrial gene expression in the early luteal phase is impacted by mode of triggering final oocyte maturation in recFSH stimulated and GnRH antagonist co-treated IVF cycles.
    Humaidan P; Van Vaerenbergh I; Bourgain C; Alsbjerg B; Blockeel C; Schuit F; Van Lommel L; Devroey P; Fatemi H
    Hum Reprod; 2012 Nov; 27(11):3259-72. PubMed ID: 22930004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of final oocyte maturation using gonadotropin-releasing hormone agonist triggering and different luteal support protocols on endometrial gene expression.
    Bermejo A; Cerrillo M; Ruiz-Alonso M; Blesa D; Simón C; Pellicer A; Garcia-Velasco JA
    Fertil Steril; 2014 Jan; 101(1):138-146.e3. PubMed ID: 24182413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of luteal-phase support on endometrial L-selectin ligand expression after recombinant follicle-stimulating hormone and ganirelix acetate for in vitro fertilization.
    Vlahos NF; Lipari CW; Bankowski B; Lai TH; King JA; Shih IeM; Fragakis K; Zhao Y
    J Clin Endocrinol Metab; 2006 Oct; 91(10):4043-9. PubMed ID: 16868054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of estradiol supplementation during the luteal phase on mouse endometrial expression of leukaemia inhibitory factor and pinopodes in controlled ovarian stimulation cycles].
    Zhang CL; Xie JK; Zhang SD; Qiao YH
    Zhonghua Fu Chan Ke Za Zhi; 2008 Dec; 43(12):937-41. PubMed ID: 19134335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accelerated endometrial maturation in the luteal phase of cycles utilizing controlled ovarian hyperstimulation: impact of gonadotropin-releasing hormone agonists versus antagonists.
    Saadat P; Boostanfar R; Slater CC; Tourgeman DE; Stanczyk FZ; Paulson RJ
    Fertil Steril; 2004 Jul; 82(1):167-71. PubMed ID: 15237007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Steroid receptor expression in late follicular phase endometrium in GnRH antagonist IVF cycles is already altered, indicating initiation of early luteal phase transformation in the absence of secretory changes.
    Papanikolaou EG; Bourgain C; Kolibianakis E; Tournaye H; Devroey P
    Hum Reprod; 2005 Jun; 20(6):1541-7. PubMed ID: 15705618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Which luteal phase support is better for each IVF stimulation protocol to achieve the highest pregnancy rate? A superiority randomized clinical trial.
    Gizzo S; Andrisani A; Esposito F; Noventa M; Di Gangi S; Angioni S; Litta P; Gangemi M; Nardelli GB
    Gynecol Endocrinol; 2014; 30(12):902-8. PubMed ID: 25268567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Luteal granulosa cells from natural cycles are more capable of maintaining their viability, steroidogenic activity and LH receptor expression than those of stimulated IVF cycles.
    Bildik G; Akin N; Seyhan A; Esmaeilian Y; Yakin K; Keles I; Balaban B; Ata B; Urman B; Oktem O
    Hum Reprod; 2019 Feb; 34(2):345-355. PubMed ID: 30520979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of luteal phase support on gene expression of extracellular matrix protein and adhesion molecules in the human endometrium during the window of implantation following controlled ovarian stimulation with a GnRH antagonist protocol.
    Zhao Y; Garcia J; Kolp L; Cheadle C; Rodriguez A; Vlahos NF
    Fertil Steril; 2010 Nov; 94(6):2264-71. PubMed ID: 20226447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Similar endometrial development in oocyte donors treated with either high- or standard-dose GnRH antagonist compared to treatment with a GnRH agonist or in natural cycles.
    Simon C; Oberyé J; Bellver J; Vidal C; Bosch E; Horcajadas JA; Murphy C; Adams S; Riesewijk A; Mannaerts B; Pellicer A
    Hum Reprod; 2005 Dec; 20(12):3318-27. PubMed ID: 16085660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined use of oestradiol and progesterone to support luteal phase in antagonist intracytoplasmic sperm injection cycles of normoresponder women: a case-control study.
    Çakar E; Tasan HA; Kumru P; Cogendez E; Usal NT; Kutlu HT; Özkaya E; Eser SK
    J Obstet Gynaecol; 2020 Feb; 40(2):264-269. PubMed ID: 31455122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral oestradiol supplementation as luteal support in IVF/ICSI cycles: a prospective, randomized controlled study.
    Lin H; Li Y; Li L; Wang W; Zhang Q; Chen X; Yang D
    Eur J Obstet Gynecol Reprod Biol; 2013 Apr; 167(2):171-5. PubMed ID: 23287635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Luteal phase support for assisted reproduction cycles.
    van der Linden M; Buckingham K; Farquhar C; Kremer JA; Metwally M
    Cochrane Database Syst Rev; 2011 Oct; (10):CD009154. PubMed ID: 21975790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment.
    Beckers NG; Macklon NS; Eijkemans MJ; Ludwig M; Felberbaum RE; Diedrich K; Bustion S; Loumaye E; Fauser BC
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4186-92. PubMed ID: 12970285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The luteal phase of cycles utilizing controlled ovarian hyperstimulation and the possible impact of this hyperstimulation on embryo implantation.
    Kolb BA; Paulson RJ
    Am J Obstet Gynecol; 1997 Jun; 176(6):1262-7; discussion 1267-9. PubMed ID: 9215183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of ovarian stimulation on mid-luteal endometrial tissue and secretion markers of receptivity.
    van der Gaast MH; Classen-Linke I; Krusche CA; Beier-Hellwig K; Fauser BC; Beier HM; Macklon NS
    Reprod Biomed Online; 2008 Oct; 17(4):553-63. PubMed ID: 18854111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The addition of gonadotrophin releasing hormone agonist to routine luteal phase support in intracytoplasmic sperm injection and embryo transfer cycles: a randomized clinical trial.
    Yıldız GA; Şükür YE; Ateş C; Aytaç R
    Eur J Obstet Gynecol Reprod Biol; 2014 Nov; 182():66-70. PubMed ID: 25238659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variable effects of RU 486 on endometrial maintenance in the luteal phase extended by exogenous hCG.
    Croxatto HB; Salvatierra AM; Croxatto HD; Spitz IM
    Clin Endocrinol (Oxf); 1989 Jul; 31(1):15-23. PubMed ID: 2598478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early luteal phase endocrine profile is affected by the mode of triggering final oocyte maturation and the luteal phase support used in recombinant follicle-stimulating hormone-gonadotropin-releasing hormone antagonist in vitro fertilization cycles.
    Fatemi HM; Polyzos NP; van Vaerenbergh I; Bourgain C; Blockeel C; Alsbjerg B; Papanikolaou EG; Humaidan P
    Fertil Steril; 2013 Sep; 100(3):742-7. PubMed ID: 23806846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.